Related Experiment Video

Updated: Jul 13, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

Asymptomatic gastric angiodysplasia in chronic hemodialysis patients: case reports

K Charfeddine1, K Kammoun, M Kharrat

  • 1Department of Nephrology, University Hospital, Sfax, Tunisia.

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
|July 28, 2007
PubMed

Insights

Gastrointestinal (GI) angiodysplasia, a vascular lesion, commonly causes bleeding in chronic renal failure (CRF). This study found asymptomatic angiodysplasia in three hemodialysis patients, suggesting its incidence may be underestimated in CRF populations.

Area of Science:

  • Gastroenterology
  • Nephrology
  • Vascular Medicine

Background:

  • Gastrointestinal (GI) angiodysplasia is a recognized vascular malformation.
  • It is a frequent cause of GI bleeding, particularly in patients with chronic renal failure (CRF).
  • The prevalence and clinical presentation in CRF patients undergoing hemodialysis require further investigation.

Purpose of the Study:

  • To report the occurrence of asymptomatic GI angiodysplasia in adult patients with CRF on chronic hemodialysis.
  • To highlight the potential underestimation of angiodysplasia incidence in this patient group.
  • To contribute to the understanding of GI vascular lesions in the context of renal disease.

Main Methods:

  • Case series reporting on three adult patients undergoing chronic hemodialysis.
  • Longitudinal observation over a four-year period.
  • Monitoring of hemoglobin levels and iron/erythropoietin (EPO) therapy status.

Main Results:

  • Three adult patients on chronic hemodialysis were found to have asymptomatic GI angiodysplasia.
  • Hemoglobin levels remained stable throughout the four-year observation period.
  • None of the patients received iron supplementation or erythropoietin (EPO) therapy during the study.

Conclusions:

  • Asymptomatic GI angiodysplasia can occur in patients with CRF on chronic hemodialysis.
  • The incidence of GI angiodysplasia in CRF patients may be higher than currently recognized.
  • Further research is warranted to elucidate the true prevalence and management strategies for angiodysplasia in CRF.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...